Department of Infection, Immunity and Inflammation, Institute for Lung Health, University of Leicester, , Leicester, UK.
Thorax. 2013 Oct;68(10):974-7. doi: 10.1136/thoraxjnl-2012-202786. Epub 2013 Apr 5.
Effective therapies for the 10% of patients with 'severe' asthma remain elusive, while other pulmonary diseases such as idiopathic pulmonary fibrosis are currently untreatable. Many cellular processes rely heavily on signals delivered by changes in the intracellular-free Ca(2+) concentration, in many cases relying on Ca(2+) influx from the extracellular fluid through specific ion channels. This Ca(2+) influx is, to some extent, dependent on the plasma membrane potential, which is controlled by the flow of other ions such as K(+) and Cl(-) through their own channels. Irrespective of the point from where pathophysiological cell function is sustained, all mechanisms are predicted to rely heavily on the activity of the final effector ion channels required for pathological cell function. Ion channels are therefore highly attractive targets for the treatment of many diverse diseases, including those affecting the lung.
对于 10%患有“严重”哮喘的患者,有效的治疗方法仍然难以捉摸,而其他肺部疾病,如特发性肺纤维化,目前还无法治疗。许多细胞过程严重依赖于细胞内游离 Ca(2+)浓度变化所传递的信号,在许多情况下,这些信号依赖于通过特定离子通道从细胞外液中流入的 Ca(2+)。这种 Ca(2+)内流在某种程度上取决于质膜电位,而质膜电位由其他离子(如 K(+)和 Cl(-))通过自身通道的流动来控制。无论维持病理细胞功能的起点在哪里,所有机制都预计严重依赖于病理性细胞功能所需的最终效应离子通道的活性。因此,离子通道是治疗许多不同疾病的极具吸引力的靶点,包括影响肺部的疾病。